| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.6222 | 
      | Human Intestinal Absorption | HIA+ | 0.9642 | 
      | Caco-2 Permeability | Caco2+ | 0.6494 | 
      | P-glycoprotein Substrate | Substrate | 0.5453 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.5230 | 
                                                     | Inhibitor | 0.6534 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8553 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8228 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7286 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8878 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5927 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8959 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.7864 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.5346 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.8365 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.6654 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5691 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9266 | 
                                                                    | Non-inhibitor | 0.9131 | 
      | AMES Toxicity | Non AMES toxic | 0.7747 | 
      | Carcinogens | Non-carcinogens | 0.8866 | 
      | Fish Toxicity | High FHMT | 0.9841 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9993 | 
      | Honey Bee Toxicity | High HBT | 0.6522 | 
      | Biodegradation | Not ready biodegradable | 0.9000 | 
      | Acute Oral Toxicity | III | 0.6250 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6580 |